Opportunity

Federal Register #2026-18263

CDC Reorganizes National Center for Immunization and Respiratory Diseases; No Procurement Involved

Buyer

Centers for Disease Control and Prevention

Posted

September 09, 2026

Identifier

2026-18263

This notice announces a reorganization within the Centers for Disease Control and Prevention (CDC), specifically affecting the National Center for Immunization and Respiratory Diseases (NCIRD). - Government Buyer: - Centers for Disease Control and Prevention (CDC), Department of Health and Human Services - Key Changes: - Consolidation of offices and retitling of divisions and branches within NCIRD - Merger of the Influenza Division and the Coronavirus and Other Respiratory Diseases Division into the new Influenza and Respiratory Viruses Division (IRVD) - IRVD includes branches for Virology and Laboratory Surveillance, Respiratory Virus Detection and Immunology, Surveillance, Epidemiology and Modeling, Public Health Interventions, and Emerging Viral Respiratory Threats - Updates to mission and function statements for affected divisions and branches - Purpose and Scope: - IRVD is responsible for prevention, surveillance, research, and response to respiratory viral diseases, including influenza and emerging viral threats - Procurement Details: - No OEMs, vendors, products, or services are being procured or requested in this notice - No quantities, part numbers, or unique technical requirements are specified

Description

The Centers for Disease Control and Prevention (CDC) has reorganized the National Center for Immunization and Respiratory Diseases (NCIRD). This reorganization includes consolidating offices, retitling divisions and branches, and modifying mission and function statements. The Influenza Division and the Coronavirus and Other Respiratory Diseases Division have been merged to form the Influenza and Respiratory Viruses Division. The new division focuses on prevention, surveillance, research, and response to respiratory viral diseases including influenza and emerging viral threats. The reorganization was approved by the Secretary of Health and Human Services and became effective on September 4, 2026.

View original listing